Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DEPO

Depomed (DEPO) Stock Price, News & Analysis

Depomed logo

About Depomed Stock (NASDAQ:DEPO)

Advanced Chart

Key Stats

Today's Range
$7.09
$7.42
50-Day Range
N/A
52-Week Range
$4.31
$9.48
Volume
940,193 shs
Average Volume
1.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Receive DEPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Depomed and its competitors with MarketBeat's FREE daily newsletter.

DEPO Stock News Headlines

Pfizer: Investor Activism Is Not The Solution
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Why DepoMed (DEPO) Stock Is Gaining Today
Opioid Litigants Get Boost From Senate Report
See More Headlines

DEPO Stock Analysis - Frequently Asked Questions

Depomed, Inc. (NASDAQ:DEPO) released its quarterly earnings results on Wednesday, August, 8th. The specialty pharmaceutical company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.03. Depomed's quarterly revenue was down 37.0% on a year-over-year basis.

Company Calendar

Last Earnings
8/08/2018
Today
5/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:DEPO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:DEPO) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners